9th Annual European Drug Safety Pharma & Biotech Conference

World’s greatest minds in drug safety, pharmacovigilance, data analysis, reporting, government policy, and innovative technology united under the Why Summits Future of Pharmacovigilance World Tour

key information



This is not just another Drug safety conference. This is a conference which tells you a STORY. One personal experience followed by another, a storyline of exceptional people who happen to choose Drug Safety and Pharmacovigilance as their way to bring needed medicines and protect those who are the most vulnerable, and to improve the health of millions of people on our planet. You will hear experts talk about the current issues in this ever-evolving industry. The best practice case studies on how to integrate new, disruptive technology into the rather rigid processes of PV organization and how it evolves to stay compliant. But how to do this with the more and more restrictive budget? How to prioritize, what methodologies to use for advanced therapies? What is the next evolution step in signal detection noise clearance? Are A.I.-based tools to become our colleagues, helpmates, or our replacement? Nonetheless, each company, department, and project starts with people. But how to build a winning cross-functional team and what kind of workforce is necessary for a drug safety department of the future? What kind of skills to expect from millennials and gen-z entering the industry and why do we need veterans in the industry as well? Challenges with innovations, outsourcing, everchanging regulatory landscape, harmonization, teaching other departments on how to use RWE data, and engaging the more and more aware public. All these topics we address, are conveyed having our mission in our mind, bringing medicines and new therapeutic indications to patients, faster, safer, and more sustainably. Our visionary keynote presentations and best practice case studies will complement engaging panel discussions with different speakers to better understand Pharmacovigilance challenges and solutions from different perspectives, with unique views coming from some of the most experienced and passionate professionals. Our conference will feature numerous assisted formal and informal networking, matchmaking, and breakout sessions to create those critical business friendships that will bring fruitful cooperation and fill that missing piece in our common mission to improve drug safety and quality of life for all.


Who will attend

“Great dialogue on key issues. Everyone shared truthful insight and did not hold back, even on negative experiences.”
Sameer Thapar
Assistant Professor & Advisor, Drug Safety and Pharmacovigilance, Rutgers University
“High-quality speakers and attendees, a great mix between healthcare providers, life science companies, providers of digital health & AI solutions, and investors.”
John Mulcahy
CEO, HealthGenuity
“Unlike some other similar events, I found relevance in every session within your conference. The content was neither too simplistic nor too advanced. The participants and presenters provided a diverse view of the issues that are present for most in this industry.”
Christine Clearwater
Manager, Safety Operations and Vendor Management, Baxter, Global Patient Safety
“Loved it. It was very practical and provided valuable insight into practical methods that are actionable for patient safety.”
Daniel Naranjo
Global Safety Lead, Global Patient Safety Evaluation, Takeda

Event Speakers

Henk Streefkerk

Chief Medical Officer
Cell Prothera

Petar Gjorgiev

Safety risk Lead & Medical Director

Dimitrios Zampatis

Global Program Safety Lead - Novartis/Sandoz

Mark Duman

Patient engagement specialist
MD Healthcare consultants

Erika Barbarosie

Associated Director Compliance
Gilead Sciences

Lionel van Holle

Safety Surveillance Lead at UCB

Tiberius Pereira

Patients for safety

Azza Elgharably

Associate Director, Patient Safety
Operations, Technology and Analytics Astrazeneca

Michael von Forstner

Global Head Clinical Safety & Pharmacovigilance

Nicole Baker


Priya Singhal

Head, SVP, Global Safety & Regulatory sciences

Shikta Das

Associate principal scientist

Rohan Mane

Director, Safety Risk Management Centre of Excellence

Henk Streefkerk

Chief Medical Officer
Cell Prothera

Leonardo Pereira

Clinical Safety Director

Sue Rees

Senior Pharmacovigilance lecturer
University of Hertfordshire

Robert Massouh

Director - Risk Management Product Lead

Zina Sadeq

Director, Regional PV & Alliance Management
Amicus Therapeutics

Riti Shah

Medical director of pharmacovigilance

Robert Adams

Global Safety Physician at Reckitt

Marko Korenjak

European Liver Patients'​ Association

Emanuel Lohrman

Emanuel Lohrmann at Ostuka pharmaceuticals

Philip Eichorn

Global Head of Drug Safety at Amryt Pharma

Ivana Rosendal

Senior Director, IT Business Partner at Ascendis pharma

Stephanie Tcherny

Global Head of Benefit-Risk Evaluation
View More Speakers





Ticket | November 29-30, 2023
  • Access to All Conference Sessions of the 9th Annual European Drug Safety Pharma & Biotech Conference Basel
  • Access to Post Conference Networking
  • Conference Materials
  • Includes Coffee Breaks, Snacks and Refreshments, Seated Lunch


  • Present on the Main Stage
  • Hold an exhibit at this event
  • Showcase your Brand in Marketing Material
  • Gain exposure through alternative partnership benefits
get the latest updates & discounts

Subcribe to our newsletter

Our Company